Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries (Trials, (2021), 22, 1, (86), 10.1186/s13063-021-05035-9)

the PREVAC study team

doi:10.1186/s13063-021-05572-3

Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries (Trials, (2021), 22, 1, (86), 10.1186/s13063-021-05035-9)

the PREVAC study team

Biostatistics

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Following the publication of the original article [1], we were notified of an error in the affiliation of 3 authors of the article: Celine Roy, Laura Richert and Genevieve Chene. Their affiliation was initially mentioned as: “Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia” However, their correct affiliation is: Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France.tp.

Original language	English (US)
Article number	583
Journal	Trials
Volume	22
Issue number	1
DOIs	https://doi.org/10.1186/s13063-021-05572-3
State	Published - Dec 2021

Bibliographical note

Publisher Copyright:
© The Author(s) 2021.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1186/s13063-021-05572-3

Find It

Find It at U of M Libraries

Fingerprint

Dive into the research topics of 'Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries (Trials, (2021), 22, 1, (86), 10.1186/s13063-021-05035-9)'. Together they form a unique fingerprint.

Cite this

the PREVAC study team (2021). Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries (Trials, (2021), 22, 1, (86), 10.1186/s13063-021-05035-9). Trials, 22(1), Article 583. https://doi.org/10.1186/s13063-021-05572-3

Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries (Trials, (2021), 22, 1, (86), 10.1186/s13063-021-05035-9). / the PREVAC study team.
In: Trials, Vol. 22, No. 1, 583, 12.2021.

Research output: Contribution to journal › Comment/debate › peer-review

the PREVAC study team 2021, 'Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries (Trials, (2021), 22, 1, (86), 10.1186/s13063-021-05035-9)', Trials, vol. 22, no. 1, 583. https://doi.org/10.1186/s13063-021-05572-3

the PREVAC study team. Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries (Trials, (2021), 22, 1, (86), 10.1186/s13063-021-05035-9). Trials. 2021 Dec;22(1):583. doi: 10.1186/s13063-021-05572-3

the PREVAC study team. / Correction to : Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries (Trials, (2021), 22, 1, (86), 10.1186/s13063-021-05035-9). In: Trials. 2021 ; Vol. 22, No. 1.

@article{999fa965996a451b973d9ff12b99c3ec,

title = "Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries (Trials, (2021), 22, 1, (86), 10.1186/s13063-021-05035-9)",

abstract = "Following the publication of the original article [1], we were notified of an error in the affiliation of 3 authors of the article: Celine Roy, Laura Richert and Genevieve Chene. Their affiliation was initially mentioned as: “Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia” However, their correct affiliation is: Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France.tp.",

author = "{the PREVAC study team} and Moses Badio and Edouard Lhomme and Mark Kieh and Beavogui, {Abdoul Habib} and Kennedy, {Stephen B.} and Seydou Doumbia and Bailah Leigh and Sow, {Samba O.} and Alpha Diallo and Daniela Fusco and Matthew Kirchoff and Monique Termote and Renaud Vatrinet and Deborah Wentworth and Hel{\`e}ne Esperou and Lane, {H. Clifford} and Jerome Pierson and Deborah Watson-Jones and C{\'e}line Roy and Eric D{\textquoteright}Ortenzio and Brian Greenwood and Genevieve Ch{\^e}ne and Laura Richer and Neaton, {James D.} and Yazdan Yazdanpanah",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2021.",

year = "2021",

month = dec,

doi = "10.1186/s13063-021-05572-3",

language = "English (US)",

volume = "22",

journal = "Trials",

issn = "1745-6215",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - Correction to

T2 - Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries (Trials, (2021), 22, 1, (86), 10.1186/s13063-021-05035-9)

AU - the PREVAC study team

AU - Badio, Moses

AU - Lhomme, Edouard

AU - Kieh, Mark

AU - Beavogui, Abdoul Habib

AU - Kennedy, Stephen B.

AU - Doumbia, Seydou

AU - Leigh, Bailah

AU - Sow, Samba O.

AU - Diallo, Alpha

AU - Fusco, Daniela

AU - Kirchoff, Matthew

AU - Termote, Monique

AU - Vatrinet, Renaud

AU - Wentworth, Deborah

AU - Esperou, Helène

AU - Lane, H. Clifford

AU - Pierson, Jerome

AU - Watson-Jones, Deborah

AU - Roy, Céline

AU - D’Ortenzio, Eric

AU - Greenwood, Brian

AU - Chêne, Genevieve

AU - Richer, Laura

AU - Neaton, James D.

AU - Yazdanpanah, Yazdan

PY - 2021/12

Y1 - 2021/12

N2 - Following the publication of the original article [1], we were notified of an error in the affiliation of 3 authors of the article: Celine Roy, Laura Richert and Genevieve Chene. Their affiliation was initially mentioned as: “Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia” However, their correct affiliation is: Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France.tp.

AB - Following the publication of the original article [1], we were notified of an error in the affiliation of 3 authors of the article: Celine Roy, Laura Richert and Genevieve Chene. Their affiliation was initially mentioned as: “Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia” However, their correct affiliation is: Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France.tp.

UR - http://www.scopus.com/inward/record.url?scp=85114299153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85114299153&partnerID=8YFLogxK

U2 - 10.1186/s13063-021-05572-3

DO - 10.1186/s13063-021-05572-3

M3 - Comment/debate

C2 - 34470655

AN - SCOPUS:85114299153

SN - 1745-6215

VL - 22

JO - Trials

JF - Trials

IS - 1

M1 - 583

ER -